Parkinson’s. Alzheimer’s. Schizophrenia. Stroke. Depression. These and a host of other debilitating neurological diseases afflict one in five Americans, at a staggering economic and social cost. But University of Minnesota neuroscientists expect to reduce that burden with advances in neuromodulation — treatments, such as deep brain stimulation, that change the activity of brain circuits.
Both the University and the state’s medical devices industry are leaders in this booming field — with Minnesota companies generating $2.2 billion in neuromodulationrelated revenue in 2011. And the state will continue to lead the way if an ambitious University initiative is approved by the legislature. The initiative, called MNDrive (Minnesota Discovery, Research, and Innovation economy), asks the state to invest $18 million in neuromodulation and three other key industries: food security, robotics, and bioremediation — the use of microorganisms to clean up hazardous wastes.
The aim: advance Minnesota’s economy, position the state as a leader in highgrowth industries, and improve Minnesotans’ quality of life.
Read more at z.umn.edu/cod.